Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
inflammation
Pharma
InflaRx charts layoffs, cost cuts to lift lead asset's prospects
Roughly 30% of the company’s staff will be laid off, accompanied by “substantial spending reductions,” InflaRx said in its announcement.
Fraiser Kansteiner
Jan 8, 2026 11:03am
New treatments needed in chronic hand eczema: GlobalData
Dec 19, 2024 3:35pm
Apellis homes in on possible source of rare Syfovre side effect
Aug 23, 2023 9:28am
Apellis bolsters case for Syfovre amid second-quarter earnings
Jul 31, 2023 9:58am
Experts report eye inflammation cases linked to Apellis' Syfovre
Jul 17, 2023 5:30pm
AstraZeneca mounts dual campaigns to discuss asthma inflammation
Jul 7, 2023 6:10am
